Beta Drugs Limited

Healthcare

NSE: BETA

About Beta Drugs Limited

No company profile on record yet.

Key facts

NSE symbolBETA
ISININE351Y01019
CINL24230HP2005PLC028969
Listing date24 Nov 2025
Fiscal year end31 Mar
SectorHealthcare
AuditorDINESH BHANDARI PRACTISING COMPANY SECRETARY (DINESH BHANDARI)
Registered officeVILLAGE NANDPUR, LODHIMAJRA ROAD, BADDI,DISTT SOLAN, H.P.

Financial performance

Full financials →
Fiscal yearMar 26Mar 25
Total income (before exceptional items)——
Net profit14—

₹ Crore. † Summed from the four quarterly filings of that fiscal year.

Board of directors

Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.

NameDesignationTerm end
ASHUTOSH SHUKLAExecutive DirectorJune 30, 2026
BALWANT SINGHExecutive DirectorJune 30, 2026
RAHUL BATRAExecutive DirectorJune 30, 2026
VARUN BATRAExecutive DirectorJune 30, 2026
LALIT KUMAR WATTSIndependent DirectorJune 30, 2026
MANMOHAN KHANNAIndependent DirectorJune 30, 2026
MONICA JAINIndependent DirectorJune 30, 2026
ROHIT PARTIIndependent DirectorJune 30, 2026
SANJAY SEHGALIndependent DirectorJune 30, 2026
AJAY MAHIPALNon-Executive DirectorJune 30, 2026

Management, subsidiaries and brands

Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.